Genistein Inhibits ox-LDL-induced VCAM-1, ICAM-1 and MCP-1 Expression of HUVECs Through Heme Oxygenase-1

Archives of Medical Research

Volumn 44, Issue 1, 2013, Pages 13-20

  Zhang, Hua ping ^a   Zheng, Feng li ^a   Zhao, Jia hui ^a   Guo, Dong xing ^a   Chen, Xiao long ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Genistein; HO 1; Inflammation; Nrf2

Indexed keywords

GENISTEIN; HEME OXYGENASE 1; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL NUCLEUS; CELL SURVIVAL; CHEMOKINE CCL2; DOWN-REGULATION; GENISTEIN; HEME OXYGENASE-1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, LDL; NF-E2-RELATED FACTOR 2; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84873128844     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.12.001     Document Type: Article

References (35)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
2. Mizuno Y., Jacob R.F., Mason R.P. Inflammation and the development of atherosclerosis. J Atheroscler Thromb 2011, 18:351-358.
3. Ramli J., CalderonArtero P., Block R.C., et al. Novel therapeutic targets for preserving a healthy endothelium: strategies for reducing the risk of vascular and cardiovascular disease. J Cardiol 2011, 18:352-363.
4. Zhang L., Zhang S., Jiang H., et al. Effects of statin therapy on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials. Arch Med Res 2010, 41:464-471.
5. Little P.J., Chait A., Bobik A. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Pharmacol Ther 2011, 131:255-268.
6. Zakynthinos E., Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol 2009, 53:317-333.
7. Nageh M.F., Sandberg E.T., Marotti K.R., et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1997, 17:1517-1520.
8. Wenzel U., Fuchs D., Daniel H. Protective effects of soy-isoflavones in cardiovascular disease. Identification of molecular targets. Hamostaseologie 2008, 28:85-88.
9. González R., Ballester I., López-Posadas R., et al. Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr 2011, 51:331-362.
10. Yi L., Jin X., Chen C.Y., et al. Chemical structures of 4-oxo-flavonoids in relation to inhibition of oxidized low-density lipoprotein (LDL)-induced vascular endothelial dysfunction. Int J Mol Sci 2011, 12:5471-5489.
11. Babu P.V., Si H., Fu Z., et al. Genistein prevents hyperglycemia-induced monocyte adhesion to human aortic endothelial cells through preservation of the cAMP signaling pathway and ameliorates vascular inflammation in obese diabetic mice. J Nutr 2012, 142:724-730.
12. de Andrade C.M., de Sá M.F., Toloi M.R. Effects of phytoestrogens derived from soy bean on expression of adhesion molecules on HUVEC. Climacteric 2012, 15:186-194.
13. Abraham N.G., Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008, 60:79-127.
14. Durante W. Protective role of heme oxygenase-1 against inflammation in atherosclerosis. Front Biosci 2011, 17:2372-2388.
15. Wu M.L., Ho Y.C., Lin C.Y., et al. Heme oxygenase-1 in inflammation and cardiovascular disease. Am J Cardiovasc Dis 2011, 1:150-158.
16. Kuhn A.M., Tzieply N., Schmidt M.V., et al. Antioxidant signaling via Nrf2 counteracts lipopolysaccharide-mediated inflammatory responses in foam cell macrophages. Free Radic Biol Med 2011, 50:1382-1391.
17. Ishizaka N., de Leon H., Laursen J.B., et al. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 1997, 96:1923-1929.
18. Chen X.L., Varner S.E., Rao A.S., et al. Laminar flow induction of antioxidant response element mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 2003, 278:703-711.
19. Ryter S.W., Alam J., Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006, 86:583-650.
20. Ishikawa K., Sugawara D., Wang Xp, et al. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 2001, 88:506-512.
21. Toba H., Shimizu T., Miki S., et al. Calcium [corrected] channel blockers reduce angiotensin II-induced superoxide generation and inhibit lectin-like oxidized low-density lipoprotein receptor-1 expression in endothelial cells. Hypertens Res 2006, 29:105-116.
22. Zhang Q., Pi J., Woods C.G., et al. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol 2010, 244:84-97.
23. Lee S.E., Jeong S.I., Yang H., et al. Fisetin induces Nrf2-mediated HO-1 expression through PKC-δ and p38 in human umbilical vein endothelial cells. J Cell Biochem 2011, 112:2352-2360.
24. Zrelli H., Matsuoka M., Kitazaki S., et al. Hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction. J Agric Food Chem 2011, 59:4473-4482.
25. Chen J.S., Huang P.H., Wang C.H., et al. Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract. Atherosclerosis 2011, 214:301-309.
26. McNally S.J., Ross J.A., James Garden O., et al. Optimization of the paired enzyme assay for heme oxygenase activity. Anal Biochem 2004, 332:398-400.
27. Bhakta D., Higgins C.D., Sevak L., et al. Phyto-oestrogen intake and plasma concentrations in South Asian and native British women resident in England. Br J Nutr 2006, 95:1150-1158.
28. Sandoval M.J., Cutini P.H., Rauschemberger M.B., et al. The soyabean isoflavone genistein modulates endothelial cell behaviour. Br J Nutr 2010, 104:171-179.
29. Sung M.J., Kim D.H., Davaatseren M., et al. Genistein suppression of TNF-alpha-induced fractalkine expression in endothelial cells. Cell Physiol Biochem 2010, 26:431-440.
30. Heeba G., Moselhy M.E., Hassan M., et al. Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1. Br J Pharmacol 2009, 156:1256-1266.
31. Leung P.O., Wang S.H., Lu S.H., et al. Simvastatin inhibits pro-inflammatory mediators through induction of heme oxygenase-1 expression in lipopolysaccharide-stimulated RAW264.7 macrophages. Toxicol Lett 2011, 207:159-166.
32. Deng Y.M., Wu B.J., Witting P.K., et al. Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 2004, 110:1855-1860.
33. Kapturczak M.H., Wasserfall C., Brusko T., et al. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 2004, 165:1045-1053.
34. Ma W., Yuan L., Yu H., et al. Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by beta-amyloid peptides 25-35 in PC12 cells. Int J Dev Neurosci 2010, 28:289-295.
35. Hernandez-Montes E., Pollard S.E., Vauzour D., et al. Activation of glutathione peroxidase via Nrf1 mediates genistein's protection against oxidative endothelial cell injury. Biochem Biophys Res Commun 2006, 346:851-859.